Parallax Volatility Advisers, L.P. Uni Qure N.V. Put Options Transaction History

Parallax Volatility Advisers, L.P.

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2023 Nov 14, 2023	SELL	$6.71 - $11.83 $1.17 Million - $2.06 Million	-173,800 Reduced 83.16%	35,200 $236,000
Q2 2023 Aug 14, 2023	BUY	$11.12 - $22.2 $1.93 Million - $3.86 Million	173,900 Added 495.44%	209,000 $2.4 Million
Q1 2023 May 15, 2023	SELL	$18.7 - $23.07 $1.87 Million - $2.3 Million	-99,900 Reduced 74.0%	35,100 $706,000
Q4 2022 Feb 14, 2023	BUY	$18.12 - $27.32 $2.45 Million - $3.69 Million	135,000 New	135,000 $3.06 Million

142

35.3M

1.54M

389K

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $300M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.